Prognostic significance of serum cholinesterase in acute myocardial infarction
Background: Autonomic dysfunction has a prognostic significance in various cardiovascular (CV) disorders, particularly atherosclerotic coronary artery disease (CAD). Previous studies are few, regarding the association of parasympathetic dysfunction with increased complications in patients with the a...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Series: | Journal of Clinical and Preventive Cardiology |
| Subjects: | |
| Online Access: | http://www.jcpconline.org/article.asp?issn=2250-3528;year=2022;volume=11;issue=3;spage=69;epage=73;aulast=Reddy |
| _version_ | 1811200292615618560 |
|---|---|
| author | Krishna Mala Konda Reddy Parvathareddy Raghava Naga Venkata Balla Praveen Nagula Srinivas Ravi Saitej Reddy Maale Monica Rachana Rayapu |
| author_facet | Krishna Mala Konda Reddy Parvathareddy Raghava Naga Venkata Balla Praveen Nagula Srinivas Ravi Saitej Reddy Maale Monica Rachana Rayapu |
| author_sort | Krishna Mala Konda Reddy Parvathareddy |
| collection | DOAJ |
| description | Background: Autonomic dysfunction has a prognostic significance in various cardiovascular (CV) disorders, particularly atherosclerotic coronary artery disease (CAD). Previous studies are few, regarding the association of parasympathetic dysfunction with increased complications in patients with the acute coronary syndrome, a subset of CAD. We aimed to study the correlation of trends in the serum cholinesterase (sChE) levels, the marker of parasympathetic activity, with the occurrence of major adverse cardiovascular events (MACEs) in ST-segment elevation myocardial infarction (STEMI) patients. Methodology: We prospectively observed the levels of sChE in patients with STEMI on the day of admission, day 3, and day 5 along with routine biochemical profile, electrocardiogram, echocardiography, and coronary angiography. The patients were monitored during the hospital stay and were followed up at 1 month for the occurrence of any MACE. The MACE monitored was cardiac death, complete heart block, arrhythmias, and heart failure. The sChE levels are laboratory dependent and a value between 4000 and 14000 IU/L was considered normal in our laboratory. A value <4000 IU/L is noted as a low sChE level. The receiver operating characteristic curve was plotted for the cut off value of the sChE levels to predict the outcomes of patients. Results: Of the 100 STEMI patients studied, the sChE levels were persistently lower in patients who had MACE compared to those without MACE during the hospital stay and at month follow-up, which was statistically significant. A sChE <3745 IU/l on day 5 predicted an increased MACE with a sensitivity of 93.55% and specificity of 92.11%. Conclusion: A persistently low sChE levels from the day of admission can predict MACE in STEMI patients. Larger studies with prolonged follow-up are required for the causal association in the future. |
| first_indexed | 2024-04-12T02:02:23Z |
| format | Article |
| id | doaj.art-4c75cc711a4b4c90bcfd2759c863593f |
| institution | Directory Open Access Journal |
| issn | 2250-3528 |
| language | English |
| last_indexed | 2024-04-12T02:02:23Z |
| publishDate | 2022-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Clinical and Preventive Cardiology |
| spelling | doaj.art-4c75cc711a4b4c90bcfd2759c863593f2022-12-22T03:52:38ZengWolters Kluwer Medknow PublicationsJournal of Clinical and Preventive Cardiology2250-35282022-01-01113697310.4103/jcpc.jcpc_18_22Prognostic significance of serum cholinesterase in acute myocardial infarctionKrishna Mala Konda Reddy ParvathareddyRaghava Naga Venkata BallaPraveen NagulaSrinivas RaviSaitej Reddy MaaleMonica Rachana RayapuBackground: Autonomic dysfunction has a prognostic significance in various cardiovascular (CV) disorders, particularly atherosclerotic coronary artery disease (CAD). Previous studies are few, regarding the association of parasympathetic dysfunction with increased complications in patients with the acute coronary syndrome, a subset of CAD. We aimed to study the correlation of trends in the serum cholinesterase (sChE) levels, the marker of parasympathetic activity, with the occurrence of major adverse cardiovascular events (MACEs) in ST-segment elevation myocardial infarction (STEMI) patients. Methodology: We prospectively observed the levels of sChE in patients with STEMI on the day of admission, day 3, and day 5 along with routine biochemical profile, electrocardiogram, echocardiography, and coronary angiography. The patients were monitored during the hospital stay and were followed up at 1 month for the occurrence of any MACE. The MACE monitored was cardiac death, complete heart block, arrhythmias, and heart failure. The sChE levels are laboratory dependent and a value between 4000 and 14000 IU/L was considered normal in our laboratory. A value <4000 IU/L is noted as a low sChE level. The receiver operating characteristic curve was plotted for the cut off value of the sChE levels to predict the outcomes of patients. Results: Of the 100 STEMI patients studied, the sChE levels were persistently lower in patients who had MACE compared to those without MACE during the hospital stay and at month follow-up, which was statistically significant. A sChE <3745 IU/l on day 5 predicted an increased MACE with a sensitivity of 93.55% and specificity of 92.11%. Conclusion: A persistently low sChE levels from the day of admission can predict MACE in STEMI patients. Larger studies with prolonged follow-up are required for the causal association in the future.http://www.jcpconline.org/article.asp?issn=2250-3528;year=2022;volume=11;issue=3;spage=69;epage=73;aulast=Reddymajor adverse cardiac eventsparasympathetic nervous systemst-segment elevation myocardial infarctionserum cholinesterase |
| spellingShingle | Krishna Mala Konda Reddy Parvathareddy Raghava Naga Venkata Balla Praveen Nagula Srinivas Ravi Saitej Reddy Maale Monica Rachana Rayapu Prognostic significance of serum cholinesterase in acute myocardial infarction Journal of Clinical and Preventive Cardiology major adverse cardiac events parasympathetic nervous system st-segment elevation myocardial infarction serum cholinesterase |
| title | Prognostic significance of serum cholinesterase in acute myocardial infarction |
| title_full | Prognostic significance of serum cholinesterase in acute myocardial infarction |
| title_fullStr | Prognostic significance of serum cholinesterase in acute myocardial infarction |
| title_full_unstemmed | Prognostic significance of serum cholinesterase in acute myocardial infarction |
| title_short | Prognostic significance of serum cholinesterase in acute myocardial infarction |
| title_sort | prognostic significance of serum cholinesterase in acute myocardial infarction |
| topic | major adverse cardiac events parasympathetic nervous system st-segment elevation myocardial infarction serum cholinesterase |
| url | http://www.jcpconline.org/article.asp?issn=2250-3528;year=2022;volume=11;issue=3;spage=69;epage=73;aulast=Reddy |
| work_keys_str_mv | AT krishnamalakondareddyparvathareddy prognosticsignificanceofserumcholinesteraseinacutemyocardialinfarction AT raghavanagavenkataballa prognosticsignificanceofserumcholinesteraseinacutemyocardialinfarction AT praveennagula prognosticsignificanceofserumcholinesteraseinacutemyocardialinfarction AT srinivasravi prognosticsignificanceofserumcholinesteraseinacutemyocardialinfarction AT saitejreddymaale prognosticsignificanceofserumcholinesteraseinacutemyocardialinfarction AT monicarachanarayapu prognosticsignificanceofserumcholinesteraseinacutemyocardialinfarction |